| Name | (2R,3S)-2-(2,2-diphenyl-1,3-benzodioxol-5-yl)-3,4-dihydro-2H-chromene-3,5,7-triol |
|---|---|
| Synonyms |
UNII-C4A4TVM56F
EINECS 287-240-1 Bencianolum Bencianol |
| Description | Bencianol is a the semisynthetic flavinoid, with anti-spasmogenic activities. |
|---|---|
| Related Catalog | |
| In Vitro | Bencianol causes a dose-related (1-100 μg/mL) reversal of contractions induced by 5-hydroxytryptamine, nor-adrenaline, angiotensin II, prostaglandin F2a, and U-46619 (a thromboxane-A2 mimetic). Bencianol is more effective against contractions induced by EC50 compared to maximal concentrations of each agent, and is least effective against the thromboxane-A2 mimetic, U-46619[1]. Bencianol (0.1-100 nM) produces cytoprotective effects against CCl4 induced cell injury on the above three parameters[2]. |
| References |
| Molecular Formula | C28H22O6 |
|---|---|
| Molecular Weight | 454.47100 |
| Exact Mass | 454.14200 |
| PSA | 88.38000 |
| LogP | 4.80740 |
| Storage condition | 2-8℃ |